Metadata
Dataset ID:
7
Study Design
Study Design Background | Inflammation assessment by in vivo PET and MRI of a Parkinson's disease model (MPTP) using the TSPO specific radiotracer [18F]VC701. Implementation of new tool analysis for mouse brain PET fully based on CT-images |
---|---|
Study Description | Molecular and imaging prodromal markers of neurodegeneration in Parkinson disease |
Study Type | preclinical |
Study Subtype | in vivo |
Publication
Paper Linked | yes |
---|---|
Paper Title | Development of a new toolbox for mouse PET-CT brain image analysis fully based on CT images and validated in a PD mouse model |
Paper Authors | Presotto L, Bettinardi V, Mercatelli D, Picchio M, Morari M, Moresco RM and Belloli S |
Affiliation | IBFM-CNR, University of Milano - Bicocca, IRCCS San Raffaele of Milan, University of Ferrara, Italy |
Paper Journal | Scientific reports |
Paper Year | 2022 |
Paper Doi | https://doi.org/10.1038/s41598-022-19872-4 |
Open Access | yes |
Updated Year | 2022 |
Study Component
Multi Modality Images | yes |
---|---|
Imaging Modality | PET/CT,MRI |
Imaging Sub Modality | T2w MRI |
Radiation | Yes |
Imaging Coverage | CT: head; PET: whole body |
Imaging Target | TSPO receptor activity |
Dataset Information
Institution | IBFM-CNR |
---|---|
Pi | Moresco Rosa Maria |
Co Pi | Belloli Sara |
Country Of Institution | Italy |
Imaging Facility | Laboratory of molecular imaging for small animal |
Euro Bio Imaging Node | MMMI Italy |
Country Of Imaging Facility | Italy |
In Vivo Experimental Parameters
Number Of Groups | 1 |
---|---|
Types Of Groups | pre- e post-MPTP (1-metil 4-fenil 1,2,3,6-tetraidro-piridina) in a test-retest study |
Overall Sample Size | 6 |
Disease Model | Parkinson's disease |
Organ Or Tissue | brain |
Sample Size For Each Group | 6 mice pre and post-treated with MPTP |
Power Calculation | none, pilot study |
Randomization | single group |
Blinding | no |
Statistical Methods | Student's t test for paired samples |
Species | Mice |
Strain | C57BL/6 |
Immune Status | Immunocompetent |
Sex | Male |
Age | Three-month-old |
Age At Start Experiment | Three-month-old |
Age At Scanning Experiment S | Three-month-old |
Weight | About 30 g |
Weight At Start Experiment | About 30 g |
Weight At End Experiment | About 30 g |
Source Of Animals | University of Ferrara, Italy |
Registry Number Of Animal Authorization | 237/2019-PR |
Experimental Procedures
Pharmacological Drug | MPTP |
---|---|
Company | MedChemExpress |
Formulation | solution from powder |
Drug Dose | 30 |
Volume | 0,3 |
Concentration | 100 mg/ml |
Site Route Of Administration | Intraperitoneally |
Frequency Of Administration | daily for 7 days |
Vehicle Or Carrier Solution Formulation | Saline |
Drug Batch Sample Number | Lot # 27361 |
Blood Sampling | no |
Surgical Procedures Including Sham Surgery | no |
Pathogen Infection Intervention And Control | no |
Analgesic Plan To Relieve Pain Suffering And Distress | no |
Anesthesia Type | Gas |
Duration | 30 |
Anesthesia Drugs | Isofluran |
Anesthesia Dose | 2% in 1L per minute/air mix |
Monitoring Regime | software remote control of the animal's vital functions (temperature, heartbeat and breathing) |
Euthanasia | yes |
Method | CO2 plus cervical dislocation |
Histology | no |
Frequency Of Imaging | Two time points |
Timing Of Imaging | Pre and post-MPTP treatment |
Overall Scan Length | 25 min for PET-CT and 70 min for MRI |
Contrast Agent Or Radio Isotope Or Challenge With Gas Molecule | Yes |
Contrast Agent Commercial Drug | [18F]VC701 |
Contrast Agent Chemical Drug | Fluoromethyl derivative of PK11195 |
Contrast Agent Dose | mean injected activity: 4,7 ± 0,3 MBq |
Injection Volume | 0,03 |
Injection Time | scanning 100 min after radiotracer's injection |
Vehicle | saline |
Route Of Administration | intravenous |
Image Acquisition
Instrument Vendor | PET-CT Molecubes; MRI Bruker |
---|---|
Instrument Type | β-Cube and X-Cube for PET and CT, respectively;Bruker Biospec 70/30 for MRI |
Instrument Specifics | PET: FOV of 72x130 mm; CT: FOV of 64x40 mm; 7Tesla MRI equipped with 450/675 mT/m gradients |
Image Acquisition Parameters | PET: 511 KeV, 30% energy resolution; CT: 40 kVp, 400 ?A (0.8 mm Al filtration) |
Correction | PET: isotope decay and random coincidences correction; CT: ring artifact correction |
Raw Data | Yes |
Qa Qc | Yes. PET: daily and mothly QC; CT: monthly QC; MRI: daily QC |
Image Correlation
Image Type | Reconstructed and quantified images |
---|---|
Image Scale | KBq/cc for PET and HU for CT, T2 relaxation time for MRI |
Format Compression | raw, DICOM and NIFTI |
Dimensions | 2D/3D |
Overall Number Of Images | 1 dataset per animal per imaging technique per time point |
Field Of View | Max FOV for PET and CT, 14x15 mm for MRI |
Dimension Extents | PET: 192x192x384; MRI: 256x96x102 |
Size Description | PET: 76.8 x 76.8 x 154 mm; MRI: 18,7 x 7 x 15 mm |
Pixel Voxel Size Description | PET: 400 µm isometric; MRI: 73 x 73 x 600 µm |
Image Processing Methods | CT-based normalization |
Image Reconstruction Algorithm | PET: OSEM (30 iterations); CT: ISRA (iterative). |
Quality Control | no |
Image Registration Algorithm | no |
Ai Enhanced Algorithm | no |
Qc Info | n/a |
Corrections | PET: acquisition decay, randoms; CT: none |
Spatial And Temporal Alignment | PET and CT images were automatically co-registered by the software; MR images were co-registered using CT |
Fiducials Used | Brain volume |
Coregistered Images | Yes |
Transformation Matrix Other Info | SPM coregistration |
Analyzed Data
Analysis Result Type | regional increase of radiotracer's uptake |
---|---|
Data Used For Analysis | VOIs analysis, p value |
Analysis Method And Details | SPM, PMOD |
Status | complete |
Ontology Terms
Ncit Imaging | NCIT:C103512,NCIT:C16809 |
---|---|
Ncit Imaging Submodality | NCIT:C180729 |
Doid | DOID:14330 |
Ncit Anatomy | NCIT:C12439 |
Ncit Species | NCIT:C14238 |
Ncit Strain | NCIT:C14424 |
Chebi Pharmaco | CHEBI:17963 |
Chebi Anesthesia | CHEBI:6015 |